Clinical Trials Browser

Phase 1 × Terminated × Polymerase Chain Reaction × Clear all

NCT01045928 2015-11-26

Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00589550 2015-06-08

PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Phase 1 Terminated

1 enrolled 2 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00492440 2012-10-18

Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer

Phase 1 Terminated

DermatologicGenitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma

NCT01126450 2012-03-20

Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer

Phase 1 Terminated

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms